Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress
George W. Booz
Free Radical Biology and Medicine (2011) Vol. 51, Iss. 5, pp. 1054-1061
Open Access | Times Cited: 223

Showing 1-25 of 223 citing articles:

Cannabidiol: State of the art and new challenges for therapeutic applications
Simona Pisanti, Anna Maria Malfitano, Elena Ciaglia, et al.
Pharmacology & Therapeutics (2017) Vol. 175, pp. 133-150
Closed Access | Times Cited: 536
Cannabidiol (CBD) and its analogs: a review of their effects on inflammation
Sumner Burstein
Bioorganic & Medicinal Chemistry (2015) Vol. 23, Iss. 7, pp. 1377-1385
Closed Access | Times Cited: 507
Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users
Marcel O. Bonn‐Miller, Matthew Tyler Boden, Meggan M. Bucossi, et al.
The American Journal of Drug and Alcohol Abuse (2013) Vol. 40, Iss. 1, pp. 23-30
Closed Access | Times Cited: 263
Cannabinoids and Epilepsy
Evan C. Rosenberg, Richard W. Tsien, Benjamin J. Whalley, et al.
Neurotherapeutics (2015) Vol. 12, Iss. 4, pp. 747-768
Open Access | Times Cited: 258
Trends in use, pharmacology, and clinical applications of emerging herbal nutraceuticals
Elizabeth M. Williamson, Xinmin Liu, Angelo A. Izzo
British Journal of Pharmacology (2019) Vol. 177, Iss. 6, pp. 1227-1240
Open Access | Times Cited: 258
Secondary Metabolites Profiled in Cannabis Inflorescences, Leaves, Stem Barks, and Roots for Medicinal Purposes
Dan Jin, Kaiping Dai, Zhen Xie, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 258
Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes
Attila Oláh, Balázs I. Tóth, István Borbíró, et al.
Journal of Clinical Investigation (2014) Vol. 124, Iss. 9, pp. 3713-3724
Open Access | Times Cited: 240
Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science
Eric P. Baron
Headache The Journal of Head and Face Pain (2018) Vol. 58, Iss. 7, pp. 1139-1186
Closed Access | Times Cited: 212
Cadmium-Induced Oxidative Stress: Focus on the Central Nervous System
Jacopo Junio Valerio Branca, Claudia Fiorillo, Donatello Carrino, et al.
Antioxidants (2020) Vol. 9, Iss. 6, pp. 492-492
Open Access | Times Cited: 208
Industrial Hemp (Cannabis sativa subsp. sativa) as an Emerging Source for Value-Added Functional Food Ingredients and Nutraceuticals
H.P. Vasantha Rupasinghe, Amy Davis, Shanthanu Krishna Kumar, et al.
Molecules (2020) Vol. 25, Iss. 18, pp. 4078-4078
Open Access | Times Cited: 193
Association Between Self-reported Prenatal Cannabis Use and Maternal, Perinatal, and Neonatal Outcomes
Daniel J. Corsi, Laura Walsh, Deborah Weiss, et al.
JAMA (2019) Vol. 322, Iss. 2, pp. 145-145
Open Access | Times Cited: 186
Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease
Alexandre Vallée, Yves Lecarpentier, Rémy Guillevin, et al.
Acta Biochimica et Biophysica Sinica (2017) Vol. 49, Iss. 10, pp. 853-866
Open Access | Times Cited: 184
Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies
David P. Finn, Simon Haroutounian, Andrea G. Hohmann, et al.
Pain (2021) Vol. 162, Iss. 1, pp. S5-S25
Open Access | Times Cited: 162
Molecular and Cellular Mechanisms of Action of Cannabidiol
Nadia Martínez Naya, Jazmin Kelly, Giuliana Corna, et al.
Molecules (2023) Vol. 28, Iss. 16, pp. 5980-5980
Open Access | Times Cited: 55
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death
Partha Mukhopadhyay, Mohanraj Rajesh, Béla Horváth, et al.
Free Radical Biology and Medicine (2011) Vol. 50, Iss. 10, pp. 1368-1381
Open Access | Times Cited: 189
Cannabidiol in Humans—The Quest for Therapeutic Targets
Simon Zhornitsky, Stéphane Potvin
Pharmaceuticals (2012) Vol. 5, Iss. 5, pp. 529-552
Open Access | Times Cited: 186
Redox Regulation of Inflammation: Old Elements, a New Story
Yunlong Lei, Kui Wang, Longfei Deng, et al.
Medicinal Research Reviews (2014) Vol. 35, Iss. 2, pp. 306-340
Closed Access | Times Cited: 174
The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis
Barbara Romano, Francesca Borrelli, Ines Fasolino, et al.
British Journal of Pharmacology (2013) Vol. 169, Iss. 1, pp. 213-229
Open Access | Times Cited: 160
Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort
Eric P. Baron, Philippe Lucas, Joshua Eades, et al.
The Journal of Headache and Pain (2018) Vol. 19, Iss. 1
Open Access | Times Cited: 159
Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice
David Cheng, Jac Kee Low, Warren Logge, et al.
Psychopharmacology (2014) Vol. 231, Iss. 15, pp. 3009-3017
Closed Access | Times Cited: 149
The Endocannabinoid System and Plant-Derived Cannabinoids in Diabetes and Diabetic Complications
Béla Horváth, Partha Mukhopadhyay, György Haskó, et al.
American Journal Of Pathology (2011) Vol. 180, Iss. 2, pp. 432-442
Open Access | Times Cited: 146
Cannabidiol as a Potential Treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the Acute and Chronic Phases
Jacqueline S. Gofshteyn, Angus A. Wilfong, Orrin Devinsky, et al.
Journal of Child Neurology (2016) Vol. 32, Iss. 1, pp. 35-40
Closed Access | Times Cited: 144
From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases
Tommaso Cassano, Rosanna Villani, Lorenzo Pace, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 118
Microarray and Pathway Analysis Reveal Distinct Mechanisms Underlying Cannabinoid-Mediated Modulation of LPS-Induced Activation of BV-2 Microglial Cells
Ana Juknat, Maciej Pietr, Ewa Kozela, et al.
PLoS ONE (2013) Vol. 8, Iss. 4, pp. e61462-e61462
Open Access | Times Cited: 110
Cannabinoids Decrease the Th17 Inflammatory Autoimmune Phenotype
Ewa Kozela, Ana Juknat, Nathali Kaushansky, et al.
Journal of Neuroimmune Pharmacology (2013) Vol. 8, Iss. 5, pp. 1265-1276
Closed Access | Times Cited: 109
Page 1 - Next Page

Scroll to top